炎明生物 Pyrotech Therapeutics

China · 7 Employees
Inappropriate activation of the immune system results in the majority of human diseases. Thus, modulation of immune system is the focus of many drug research and development programs, which are targeting inflammation-related diseases as diverse as cancer, sepsis and Alzheimer's. Pyrotech Therapeutics is a newcomer in this field but is rapidly become world-recognized for its innovative science and first-in-class programs. Pyrotech is based on ground-breaking discoveries in the laboratory of its scientific co-founder regarding ‘pyroptosis', which is a type of cell death that controls infections by stimulating strong immune responses. However, this often beneficial highly inflammatory cell death occurs not only in the presence of pathogens but also results from other types of stimuli and injuries. Consequently, an exaggerated or inappropriate immune response can result in both acute and chronic harm to many organs. Identifying molecules that inhibit excessive and harmful immune reactions is one cornerstone of Pyrotech's programs. Conversely, Pyrotech has also discovered molecules that can exaggerate pyroptosis in cancer cells; these can lead to the eradication of tumors. Pyrotech was founded in early 2021 by Professor Feng Shao of the National Institute of Biological Sciences, Beijing, and Dr. TJ Deng, formerly the CEO of BioDuro China. In just one year, Pyrotech has built a 40,000-square feet of start-of-the-art research center in the Life Science Park of Beijing, and smaller facilities in Shanghai and San Diego. As of today, it employs 100+ experts in drug discovery, medicinal chemistry and clinical development. Several of the company's small molecule and biologic immune modulators are advancing quickly into clinical studies and the pipeline continues to expand. Pyrotech aspires to become the first China-centric biopharmaceutical company that competes and partners globally with established major pharma companies.

概述

国家 China
成立时间 2020
总部 昌平区医科路9号院, 1号楼7层, 北京, 北京 102206, CN
电话号码
网站
LinkedIn http://www.linkedin.com/company/pyrotech-therapeutics
Twitter
Facebook
员工数 7
行业 biotechnology,
简介 Inappropriate activation of the immune system results in the majority of human diseases. Thus, modulation of immune system is the focus of many drug research and development programs, which are targeting inflammation-related diseases as diverse as cancer, sepsis and Alzheimer's. Pyrotech Therapeutics is a newcomer in this field but is rapidly become world-recognized for its innovative science and first-in-class programs. Pyrotech is based on ground-breaking discoveries in the laboratory of its scientific co-founder regarding ‘pyroptosis', which is a type of cell death that controls infections by stimulating strong immune responses. However, this often beneficial highly inflammatory cell death occurs not only in the presence of pathogens but also results from other types of stimuli and injuries. Consequently, an exaggerated or inappropriate immune response can result in both acute and chronic harm to many organs. Identifying molecules that inhibit excessive and harmful immune reactions is one cornerstone of Pyrotech's programs. Conversely, Pyrotech has also discovered molecules that can exaggerate pyroptosis in cancer cells; these can lead to the eradication of tumors. Pyrotech was founded in early 2021 by Professor Feng Shao of the National Institute of Biological Sciences, Beijing, and Dr. TJ Deng, formerly the CEO of BioDuro China. In just one year, Pyrotech has built a 40,000-square feet of start-of-the-art research center in the Life Science Park of Beijing, and smaller facilities in Shanghai and San Diego. As of today, it employs 100+ experts in drug discovery, medicinal chemistry and clinical development. Several of the company's small molecule and biologic immune modulators are advancing quickly into clinical studies and the pipeline continues to expand. Pyrotech aspires to become the first China-centric biopharmaceutical company that competes and partners globally with established major pharma companies.

常见问题

炎明生物 Pyrotech Therapeutics 在哪里?

炎明生物 Pyrotech Therapeutics 的总部位于 昌平区医科路9号院, 1号楼7层, 北京, 北京 102206, CN

炎明生物 Pyrotech Therapeutics 的电话号码是多少?

炎明生物 Pyrotech Therapeutics 的电话号码是

炎明生物 Pyrotech Therapeutics 的官方网站是什么?

炎明生物 Pyrotech Therapeutics 的公司官方网站是

炎明生物 Pyrotech Therapeutics 是做什么的?

炎明生物 Pyrotech Therapeutics 的业务有哪些?

炎明生物 Pyrotech Therapeutics 的年收入是多少?

炎明生物 Pyrotech Therapeutics 的收入是 0美元

炎明生物 Pyrotech Therapeutics 有多少员工?

炎明生物 Pyrotech Therapeutics 有 7 名员工

炎明生物 Pyrotech Therapeutics 属于哪个行业?

炎明生物 Pyrotech Therapeutics 从事以下行业: biotechnology

炎明生物 Pyrotech Therapeutics 使用什么技术?

炎明生物 Pyrotech Therapeutics 使用的一些流行技术包括:

如何联系 炎明生物 Pyrotech Therapeutics?

炎明生物 Pyrotech Therapeutics 联系信息: 电话号码:, 网站:, 邮箱:ema***@***.com

炎明生物 Pyrotech Therapeutics 的社交媒体链接是什么?

炎明生物 Pyrotech Therapeutics 领英:http://www.linkedin.com/company/pyrotech-therapeutics,fackbook:,twitte:

炎明生物 Pyrotech Therapeutics 是一家上市公司吗?

不是

炎明生物 Pyrotech Therapeutics 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 炎明生物 Pyrotech Therapeutics?

炎明生物 Pyrotech Therapeutics 有 0 家投资者,包括 。

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google